We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.32B
AUM Growth
-$8.54M
Cap. Flow
+$6.65M
Cap. Flow %
0.5%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$6.65M
2
STAA icon
STAAR Surgical
STAA
+$44

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 43.07%
2 Consumer Staples 31.33%
3 Industrials 16.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$513M 38.77%
10,768,431
+1
+0% +$44
MNST icon
2
Monster Beverage
MNST
$94.3B
$414M 31.33%
8,295,690
– –
AXON
3
Axon Enterprise
AXON
$42.5B
$224M 16.91%
760,062
– –
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$115M 8.68%
566,000
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$41.6M 3.14%
41,666,255
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$14.5M 1.1%
4,929,066
+2,420,000
+96% +$6.65M
SER icon
7
Serina Therapeutics
SER
$30M
$816K 0.06%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Broadwood Capital held 7 positions worth $1.32B, down 0.64% from $1.33B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 36% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q2 2024, an estimated $6.65M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.32B portfolio in Q2 2024.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2024.
  • Broadwood Capital's portfolio value fell 0.64% quarter-over-quarter to $1.32B.

Based on Broadwood Capital's 13F filing for Q2 2024, filed 14 Aug 2024.